Stoke Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2M | 306k | 23.50 |
| 2025-06-30 | $4.0M | 353k | 11.35 |
| 2025-03-31 | $1.1M | 172k | 6.65 |
| 2024-12-31 | $2.0M | 178k | 11.03 |
| 2024-09-30 | $963k | 78k | 12.29 |
| 2024-06-30 | $1.6M | 118k | 13.51 |
| 2024-03-31 | $532k | 39k | 13.50 |
| 2023-12-31 | $157k | 30k | 5.26 |
| 2023-09-30 | $80k | 20k | 3.94 |
| 2023-06-30 | $245k | 23k | 10.62 |
| 2023-03-31 | $117k | 14k | 8.33 |
| 2022-12-31 | $136k | 15k | 9.23 |
| 2022-09-30 | $47k | 3.7k | 12.73 |
| 2022-03-31 | $1.1M | 52k | 21.04 |
| 2021-12-31 | $1.0M | 43k | 23.99 |
| 2021-09-30 | $835k | 33k | 25.45 |
| 2021-06-30 | $143k | 4.2k | 33.71 |
| 2021-03-31 | $1.8M | 46k | 38.84 |
| 2020-12-31 | $1.4M | 22k | 61.92 |
| 2020-03-31 | $100k | 4.4k | 22.83 |
| 2019-12-31 | $259k | 9.1k | 28.31 |
| 2019-09-30 | $131k | 6.1k | 21.57 |
| 2019-06-30 | $44k | 1.5k | 28.95 |